Influence of delayed initiation of therapy on the course of disease in hepatocellular carcinoma
Recruiting
- Conditions
- C22Malignant neoplasm of liver and intrahepatic bile ducts
- Registration Number
- DRKS00033834
- Lead Sponsor
- MU Klinik und Poliklinik für Radiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
HCC patients =18 years
- Presence of multiphasic cross-sectional imaging (MRI and CT) at initial diagnosis and immediately prior to local therapy
- No additional treatment of HCC prior to local therapy
Exclusion Criteria
- Incomplete or insufficient imaging that impairs correct image interpretation (e.g. due to artifacts or lack of the correct contrast agent phases).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study aims to gain valuable insights from existing data to deepen the understanding of the impact of delayed treatment initiation on disease progression in hepatocellular carcinoma.
- Secondary Outcome Measures
Name Time Method Definition of the optimal time interval between HCC diagnosis and initiation of local therapy.